<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04192643</url>
  </required_header>
  <id_info>
    <org_study_id>ALKU EDUCATION AND RESEARCH</org_study_id>
    <nct_id>NCT04192643</nct_id>
  </id_info>
  <brief_title>INTERVENTION WITH TRANEXAMIC ACID TO REDUCE HAEMORRHAGE DURING LAPAROSCOPIC MYOMECTOMY</brief_title>
  <official_title>THE IMPACT OF TRANEXAMIC ACID USAGE DURING LAPAROSCOPIC MYOMECTOMY</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Alkü Alanya Education and Research Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Alkü Alanya Education and Research Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>Yes</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      This research is planned as a randomised double-blind controlled trial. interventions to
      reduce haemorrhage during laparoscopic myomectomy for fiboids is important. İntraoperative
      Tranexamic acid usage can reduce haemorrhage and related symptoms when given during
      laparoscopic myomectomy. There is no randomised controlled trials in literature about
      tranexamic acid usage in laparoscopic gynecological operations.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      researchers planned this trial by firstly randomising the patients. 1 gr tranexamic acid in
      100 ml salin will bi given by initial of the anesthesia of the patient, the other group will
      be taken only 100ml saline solution. Randomising will be double blind and only
      anesthesiologist will see if the paient is in working group or control group. Than
      researchers provide laparoscopic myomectomy with same prothocol to each patient. At the end
      of the operation, researchers will record all the parameters during operation like; operation
      starting and ending time, the amount of bleeding, time of suturing, the size, location and
      count of myoma uteri, complications, weight of myoma uteri and the change of haemoglobine
      levels before and after operation.
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">December 30, 2020</start_date>
  <completion_date type="Anticipated">December 30, 2021</completion_date>
  <primary_completion_date type="Anticipated">December 1, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <intervention_model_description>PROSPECTİVELY DOUBLE-BLİND RANDOMİSED CONTROLLED TRİAL</intervention_model_description>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Single (Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>amount of bleeding during operation</measure>
    <time_frame>0 minute - 180 minute</time_frame>
    <description>total amount of bleeding during surgery</description>
  </primary_outcome>
  <primary_outcome>
    <measure>operation duration time</measure>
    <time_frame>0 minute - 180 minute</time_frame>
    <description>time between initial and end of the surgery</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Uterine Fibroid</condition>
  <condition>Myoma;Uterus</condition>
  <condition>Tranexamic Acid Adverse Reaction</condition>
  <arm_group>
    <arm_group_label>TRANEXAMİC ACİD</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>. 1 gr tranexamic acid in 100 ml salin given in 15 minutes</description>
  </arm_group>
  <arm_group>
    <arm_group_label>NO TRANEXAMİC ACİD</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>100 ml salin solution</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Tranexamic Acid 100 MG/ML</intervention_name>
    <description>1 GR TRANEXAMİC ACİD İN 100 ML SALİNE SOLUTİON GİVEN İN 15 MİNUTES</description>
    <arm_group_label>TRANEXAMİC ACİD</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebos</intervention_name>
    <description>100 ML SALİNE SOLUTİON</description>
    <arm_group_label>NO TRANEXAMİC ACİD</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  myoma uteri

          -  appropiate for laparoscopy

        Exclusion Criteria:

          -  malignancy
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>16 Years</minimum_age>
    <maximum_age>45 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>MERAL TUĞBA ÇİMŞİR</last_name>
    <phone>05064742272</phone>
    <email>dr.tugbaacar@gmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Alku Alanya Education and Research Hospital</name>
      <address>
        <city>Antalya</city>
        <country>Turkey</country>
      </address>
    </facility>
    <contact>
      <last_name>MERAL TUĞBA ÇİMŞİR</last_name>
      <phone>05064742272</phone>
      <email>DR.TUGBAACAR@GMAİL.COM</email>
    </contact>
  </location>
  <location_countries>
    <country>Turkey</country>
  </location_countries>
  <verification_date>June 2020</verification_date>
  <study_first_submitted>December 4, 2019</study_first_submitted>
  <study_first_submitted_qc>December 9, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">December 10, 2019</study_first_posted>
  <last_update_submitted>June 21, 2020</last_update_submitted>
  <last_update_submitted_qc>June 21, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">June 23, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Alkü Alanya Education and Research Hospital</investigator_affiliation>
    <investigator_full_name>MERAL TUĞBA ÇİMŞİR</investigator_full_name>
    <investigator_title>ASSOCIATE PROFESSOR</investigator_title>
  </responsible_party>
  <keyword>uterin fibroid, laparoscopic myomectomy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Leiomyoma</mesh_term>
    <mesh_term>Myofibroma</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Tranexamic Acid</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

